These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2192070)

  • 41. Modeling U-Shaped Exposure-Response Relationships for Agents that Demonstrate Toxicity Due to Both Excess and Deficiency.
    Milton B; Farrell PJ; Birkett N; Krewski D
    Risk Anal; 2017 Feb; 37(2):265-279. PubMed ID: 27043736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A general classification of U-shaped dose-response relationships in toxicology and their mechanistic foundations.
    Calabrese EJ; Baldwin LA
    Hum Exp Toxicol; 1998 Jul; 17(7):353-64. PubMed ID: 9726531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implications for human health.
    Golberg L
    Environ Health Perspect; 1979 Oct; 32():273-7. PubMed ID: 540600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Algebraic potential of the Hill equation as an alternative tool for plotting dose (or time)/effects relationships in toxicology: a theoretical study.
    Bounias M
    Fundam Clin Pharmacol; 1989; 3(1):1-9. PubMed ID: 2714727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of intermediate end-points to prevent long-term outcomes.
    Mutti A
    Toxicol Lett; 1995 May; 77(1-3):121-5. PubMed ID: 7618125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The curve doses vs survival time in the evaluation of acute toxicity.
    Molinengo L
    J Pharm Pharmacol; 1979 May; 31(5):343-4. PubMed ID: 37311
    [No Abstract]   [Full Text] [Related]  

  • 47. Interactions: dose effect relationships and isoeffect curves.
    Gerber GB
    Radiat Environ Biophys; 1982; 20(4):235-43. PubMed ID: 7146317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The risk of risk assessment.
    Houk VN
    Biomed Environ Sci; 1989 Mar; 2(1):48-53. PubMed ID: 2590492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uncertainty of the slope determination by the moving average method.
    Weil CS
    Toxicol Appl Pharmacol; 1986 Feb; 82(2):386-7. PubMed ID: 3945965
    [No Abstract]   [Full Text] [Related]  

  • 50. From comparative physiology to toxicological risk assessment.
    Koeman JH
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 100(1-2):7-10. PubMed ID: 1677876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Illumination of therapeutics by toxicology: a personal view.
    Pond SM
    Clin Exp Pharmacol Physiol; 1996; 23(10-11):1010-3. PubMed ID: 8911752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predicting the toxic dose or concentration. Is there a difference?
    Jochemsen R
    Arch Toxicol Suppl; 1994; 16():169-75. PubMed ID: 8192578
    [No Abstract]   [Full Text] [Related]  

  • 53. Mixtures of toxic agents and attributable risk calculations.
    Seiler FA; Scott BR
    Risk Anal; 1987 Mar; 7(1):81-90. PubMed ID: 3615995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How should we regard risks?
    Dayan AD
    Hum Exp Toxicol; 1991 Nov; 10(6):389-90. PubMed ID: 1687846
    [No Abstract]   [Full Text] [Related]  

  • 55. Generalized analysis of quantal dose-response curves.
    de Jong RH
    Comput Biomed Res; 1973 Dec; 6(6):588-95. PubMed ID: 4773187
    [No Abstract]   [Full Text] [Related]  

  • 56. The effects of caffeine and exercise on body weight, fat-pad weight, and fat-cell size.
    Wilcox AR
    Med Sci Sports Exerc; 1982; 14(4):317-21. PubMed ID: 7132651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.
    Sinha RA; Farah BL; Singh BK; Siddique MM; Li Y; Wu Y; Ilkayeva OR; Gooding J; Ching J; Zhou J; Martinez L; Xie S; Bay BH; Summers SA; Newgard CB; Yen PM
    Hepatology; 2014 Apr; 59(4):1366-80. PubMed ID: 23929677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute and chronic effects of selective serotonin reuptake inhibitor treatment on fear conditioning: implications for underlying fear circuits.
    Burghardt NS; Bauer EP
    Neuroscience; 2013 Sep; 247():253-72. PubMed ID: 23732229
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dietary Minerals and Incident Cardiovascular Outcomes among Never-Smokers in a Danish Case-Cohort Study.
    Fruh V; Babalola T; Sears C; Wellenius GA; Webster TF; Mann KK; Harrington J; Tjønneland A; Raaschou-Nielsen O; Claus Henn B; Meliker JR
    Int J Environ Res Public Health; 2024 Jul; 21(7):. PubMed ID: 39063508
    [No Abstract]   [Full Text] [Related]  

  • 60. β-Carboline (FG-7142) modulates fear but not anxiety-like behaviour in zebrafish.
    Scatterty KR; Hamilton TJ
    Sci Rep; 2024 Jan; 14(1):668. PubMed ID: 38182703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.